Maddalena Ferrana, PhD, is an assistant professor of pharmaceutical and health economics. She received a PhD in economics from Toulouse School of Economics and was a values and public policy postdoctoral fellow at Princeton University. Prior to joining USC, she was a research associate at the Harvard T.H. Chan School of Public Health. Her main […]
An expert in scientific exchange and regulatory considerations affecting product commercialization.
Dr. Amit Patel is an adjunct lecturer at the USC School of Pharmacy. He teaches graduate courses in the Healthcare Decision Analysis and Biopharmaceutical Marketing programs at the school. Dr. Patel has 15+ years of experience in biopharmaceutical market access, pricing, reimbursement strategy consulting and research. Currently, he is Vice President, PRMA Strategy and Operations […]
James Wabby, MHMS is Executive Director of Regulatory Affairs, focusing on Emerging Technologies and CMC-Device at AbbVie, based in Irvine, CA. Wabby has over 15 years of experience in many facets of regulatory affairs, quality compliance and quality operations within the GxP regulated environment pertaining to Medical Devices, Combination Products, and Digital Medicine. Wabby regularly […]
Dr. Keith Morel is VP of Regulatory Compliance at Qserve Group, the largest EU based medical device consulting company. He heads up the Redwood City office, which along with the Boston, Amsterdam (HQ) and Nanjing make up Qserve’s main office locations. He has worked in the medical device industry since 2000. Prior to joining Qserve, […]
Kellie Ann Moore, Esq, is a practical business savvy attorney with over 19 years of experience providing legal counsel to pharmaceutical, biologic and medical device organizations for compliant conduct in conformance with FDA and international regulations. Moore thrives on helping organizations strategically (and contractually) drive their FDA-regulated products and R&D services forward. By mapping contractual relationships and identifying regulatory risk mitigation strategies proactively, Moore utilizes her unique […]
Dana Bell, PhD, MS, is an RA/QA consultant specializing in the development of registration strategies and quality systems for drugs, genetically-engineered and plasma-based products. She is a part-time faculty at the USC School of Pharmacy, Department of Regulatory and Quality Sciences. Previously, Dr. Bell was Senior Director of Global Regulatory Affairs at Baxter Healthcare Corporation. […]
Dr. Meredith Smith is a behavioral scientist and health services researcher by training with over 15 years of professional experience in the pharmaceutical industry in the areas of health outcomes research, health policy, drug safety, and risk management. In her current role as Director of Risk Management at Alexion Inc., she oversees a state-of-the-art risk management […]